Information Solutions (3rd Quater Fiscal 2007 Earnings)

All of our businesses were generally strong in such fields as the medical imaging business, where we recorded robust sales of such products as the medical imaging SYNAPSE network system and endoscopes; the graphic arts business, where CTP plate sales grew, and the flat panel display materials field, where our measures to expand our manufacturing capacity for principal products contributed to higher sales.
Additional contributions to sales were made by newly consolidated subsidiaries, such as FUJIFILM IMAGING COLORANTS LIMITED, which has developed a favorable position in ink materials for ink-jet printers, and Daiichi Radioisotope Laboratories, Ltd., which is engaged in the radiopharmaceutical business (name to be changed to FUJIFILM RI Pharma Co., Ltd. on April 1, 2007).
Consolidated revenue of the segment totaled ¥265.1billion, up 19.5% over the same quarter of the previous fiscal year.

We were able to greatly increase segment operating income, to ¥ 39.0billion. This level of segment operating income is up ¥16.6 billion, or 73.7%, from the same period of the previous fiscal year.

Although operating income in the segment was impacted by higher costs associated with the high price of silver and aluminum, the Company was able to offset this through profit growth based on higher unit sales of such products as flat panel display materials, endoscopes, and CTP plates.
Another principal factor behind higher segment operating income was the fixed cost reductions enabled by streamlining manufacturing facilities that also handle in the Imaging Solutions segment.

• Fiscal Year 2008 (April 1, 2007 - March 31, 2008)
• Fiscal Year 2007 (April 1, 2006 - March 31, 2007)
• Fiscal Year 2006 (April 1, 2005 - March 31, 2006)
• Fiscal Year 2005 (April 1, 2004 - March 31, 2005)